Join our new priority response service
Complex regulatory challenges for lab grown ingredients
New QP loyalty scheme launched
Diversity & Inclusion
Insights & resources
Cellular therapy products represent a new wave in pharmaceuticals and include cellular immunotherapies, cancer vaccines and other types of both autologous and allogeneic cells for certain therapeutic indication. While the products are novel, sterility assurance concerns remain fundamental.
Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.
Switchboard: +44 (0)118 918 4000
+44 (0)118 918 4076
We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.